GC Biopharma Technographics

Discover the latest software purchases and digital transformation initiatives being undertaken by GC Biopharma and its business and technology executives. Each quarter our research team identifies on-prem and cloud applications that are being used by the 2009 GC Biopharma employees from the public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources.

During our research, we have identified that GC Biopharma has purchased the following applications: Google Cloud Platform (GCP) for Application Hosting and Computing Services in 2022, Koerber PAS-X MES for Manufacturing Execution System in 2025, Google Tag Manager for Tag Management in 2025 and the related IT decision-makers and key stakeholders.

Our database provides customer insight and contextual information on which enterprise applications and software systems GC Biopharma is running and its propensity to invest more and deepen its relationship with Google , Koerber AG or identify new suppliers as part of their overall Digital and IT transformation projects to stay competitive, fend off threats from disruptive forces, or comply with internal mandates to improve overall enterprise efficiency.

We have been analyzing GC Biopharma revenues, which have grown to $1.17 billion in 2024, plus its IT budget and roadmap, cloud software purchases, aggregating massive amounts of data points that form the basis of our forecast assumptions for GC Biopharma intention to invest in emerging technologies such as AI, Machine Learning, IoT, Blockchain, Autonomous Database or in cloud-based ERP, HCM, CRM, EPM, Procurement or Treasury applications.